NasdaqCMUSD
InMed Pharmaceuticals Inc.
$.-0.7%
52w low $0.58$2.50 52w high
Market data
- 52w range
- $0.58 - $2.50
- Sector
- Unknown
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Valuation
Overall Rating
0
Not rated
Moat Score0
Fair value estimate
Not covered by our valuation model yet.
Moat, fair value and rating computed by our valuation engine (ported from the original Python model).
Fundamentals
Market Cap
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
0.0%
Debt / Equity
0.00
Beta
0.00